<DOC>
	<DOCNO>NCT02139007</DOCNO>
	<brief_summary>This pilot study evaluate recruitment strategy sit patient , data collection instrument , follow-up procedure , administrative process , propose management strategy future large scale national trial . This pilot study 6 month length .</brief_summary>
	<brief_title>Effectiveness DiscontinuinG bisphosphonatEs Study : R21 Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>1.Females 65+ 2.3+ year alendronate ( Fosamax/Binosto ) use 3 . Valid social security number 1 . History metabolic bone condition , Paget Disease Bone 2 . Currently receive treatment ongoing cancer , exclude nonmelanoma skin cancer . 3 . Has significant underlying illness would expect prevent completion study ( e.g. , lifethreatening disease likely limit survival le 3 year ) ? 4 . HIV positive 5 . Involved conflicting ( investigational drug ) clinical trial</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>